Search TradeFlow

Search

MedImmune y Abpro llegan a un acuerdo de colaboración para un nuevo anticuerpo bioespecífico

GAITHERSBURG, Maryland AND WOBURN, Massachusetts, November 30, 2016 /PRNewswire/ —
El acuerdo crea una nueva compañía separada, AbMed, como filial de Abpro
MedImmune, brazo mundial de investigación y desarrollo de biología de AstraZeneca, y Abpro, una compañía de ciencias de la…

READ FULL ARTICLE

Energy

Disclaimer

This is not an offer to buy or sell securities. Oil investment carries with it very high risks. The information contained within this site has not been nor will it be verified by Envestor First and is subject to change at any time. We are not a United States Securities Dealer or Broker or United States Investment Adviser. Do your own due diligence and consult with a licensed professional before making any investment decisions. Please read our full disclaimer before making any decisions.